Schedule 13D ownership disclosure

BIOCRYST PHARMACEUTICALS INC

Security class unavailable · CUSIP: 09058V103

Event date: 2018-02-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,478,275
Percent of class
7.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-18-000522
Form type
SC 13D
Filer
BIOCRYST PHARMACEUTICALS INC
CIK
CIK 882796
Filed
Feb 16, 2018
Reporting period
Feb 06, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub